New Agreement with ALASK OMEGA (USA) for Omega Peptide IPH 7 and IPH 3

Ideal Pharma Peptide (Germany) is pleased to announce a new agreement with ALASK OMEGA (USA), a company with a presence in the global market since 1981, specializing in the production of raw materials for dietary supplements, children’s, and sports nutrition. ALASK OMEGA is known for its strict monitoring of the production and purification process of Omega 3 and Omega 7 raw materials derived from fresh salmon species inhabiting the pristine ecological zone of Alaska.

Together, the companies will introduce a completely new raw product to the global market: the dry form of Omega Peptide IPH 7 and Omega Peptide IPH 3 with the peptide complex IPH AG. The regulatory peptide complex IPH AG present in the composition acts as a natural bioregulator, exerting exclusively local action in the intestinal lumen, contributing to:

• Improvement of the functional state of the mucous membrane and metabolic processes in enterocytes.
• Enhancement of the activity of enterocyte transport systems for the transfer of amino acids, fatty acids, vitamins, minerals, and trace elements from the intestine into the blood.
• Prevention of the penetration of pathogenic microorganisms from the intestine into the blood.
• Strengthening of the immune system of the intestinal wall.
• Increased absorption of active components in the intestinal wall.
• Improvement of the composition of the intestinal microbiome and activation of processes therein to prevent the formation of pathogenic microflora and toxins.